Sanjoinine A

isolated from Zizyphi Spinosi Semen; structure in first source

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Weight Loss (Weight Reduction) 11/01/2009 - "Oral administration of sanjoinine A (4 and 8 mg/kg) increased the survival rate and latency of convulsion onset, and decreased the seizure scores and the weight loss induced by intraperitoneal (i.p.) injection of KA (50 mg/kg) in mice. " 09/01/2008 - "Administration of sanjoinine A increased the survival rate and the latency of seizure onset, and decreased the seizure scores and the weight-loss induced by NMDA in mice, in a dose-dependent manner. "
2.	Seizures (Absence Seizure) 09/01/2008 - "It is suggested that sanjoinine A protects against NMDA-induced seizures by inhibiting intracellular calcium influx."
3.	Sleep Initiation and Maintenance Disorders (Insomnia) 09/01/2023 - "The established method was applied to assign the absolute configuration of the N,N-dimethyl phenylalanine in sanjoinine A (4), a cyclopeptide alkaloid isolated from Zizyphi Spinosi Semen widely used as herbal medicine for insomnia. "

1.	Oral Administration